Skip to main content
Clinical Trials/NL-OMON46101
NL-OMON46101
Withdrawn
Phase 2

A randomized pilot study on probiotics and their effect on vitamin K2 status - ProVitaK

Winclove B.V.0 sites20 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
10047635
Sponsor
Winclove B.V.
Enrollment
20
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Winclove B.V.

Eligibility Criteria

Inclusion Criteria

  • \* High cardiovascular risk without type 2 diabetes \* at least 1 of the following risk factors:
  • o systolic blood pressure \> 140mm Hg, diastolic blood pressure \> 90 mmHg or use of blood pressure lowering medication and/or
  • o impaired glucose tolerance \* 2 hour glucose levels of 7\.8 to 11\.0 mmol/L after 75 gram oral glucose tolerance test
  • o Family history of cardiovascular disease \< 65 years
  • o Total cholesterol \> 6\.5 mmol/l or use of statins
  • o Smokers \* 50 years
  • o Estimated glomerular filtration rate \< 60 ml/min
  • \* No gastrointestinal tract problems/stool problems

Exclusion Criteria

  • \* Pregnancy, lactation or a female planning to conceive within the study period
  • \* Diabetes of any type.
  • \* Age \<50 or \* 70 years
  • \* Body mass index \< 20 or \> 39 kg/m2
  • \* Using vitamin supplements that contain vitamin K, or unwilling to stop two weeks before randomization.

Outcomes

Primary Outcomes

Not specified

Similar Trials